Quick News Bit

Bharat Biotech readying to start making vaccine from Pune plant

0
It takes the company around 120 days for the roll out of vaccines from start to supply stage.

Bharat Biotech is slated to start manufacturing the Covaxin from its plant at Manjari, near Hadapsar in Pune, from December.

Bharat Biotech has repurposed the facilities of Biovet, an associate company, for making the Covid-19 vaccine. This facility, earlier owned by Intervet India, a subsidiary of Merck & Co, was into production of foot and mouth disease vaccines. Intervet India exited this business in India and transferred the land and manufacturing unit to Biovet.

Bharat Biotech has been working on the production line and building human resources for Covid-19 vaccine production at this plant. The company had started manufacturing the initial batches of the Covaxin Covid-19 vaccine at the Manjari plant and a commercial rollout was expected in December.

It takes the company around 120 days for the roll out of vaccines from start to supply stage.

The company has received local clearances and administrative approvals for its Pune plant and as per initial plans, it was supposed to start production in August 2021. The Pune district administration had handed over a 12 hectare plot to Bharat Biotech for vaccine production in May 2021. District officials had said the plant would have an annual capacity to make 7.5 crore vaccine doses.

The plant has received approvals from the Maharashtra State Electricity Distribution Company, Food and Drug Administration, Central Pollution Control Board and Labor Department.

Krishna Ella, chairman and managing director of Bharat Biotech, has said that his company would have an annualised capacity of 100 crore doses by December end. Bharat Biotech has plans to make around 10 crore vaccines a month across its facilities in Hyderabad in Telangana, Malur in Karnataka, Ankleshwar in Gujarat and now Pune.

At present, the company is producing around 5.5 crore doses per month.

The country has administered 13.11 crore doses of Covaxin till date. The company did not respond to queries regarding production plan and vaccine roll out at the Pune plant.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

For all the latest Life Style News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment